13Jan 2024
Anemia in patients ≥ 75 years with metastatic clear cell renal cell carcinoma

Anemia in patients ≥ 75 years with metastatic clear cell renal cell carcinoma

This study investigated the characteristics and outcomes of systemic therapies in Japanese patients with metastatic renal cell carcinoma (mRCC), specifically comparing patients aged ≥75 years with those aged <75 years. The analysis included 206 patients, with 47 in the ≥75 years group. Differences in clinical factors, International Metastatic RCC Database Consortium (IMDC) risk factors, and survival outcomes were assessed. The study found a higher proportion of baseline anemia in elderly patients, leading to a higher rate of IMDC intermediate/poor risk and shorter overall survival (OS) and cancer-specific survival (CSS). Elderly patients also tended to receive best supportive care (BSC) instead of second-line active treatment.

  • #urology

Like

Save

Share